Results 31 to 40 of about 8,380,026 (270)

Cutaneous Squamous Cell Carcinoma While on Vismodegib Therapy for Locally Advanced Basal Cell Carcinoma

Actas Dermo-Sifiliográficas
B. Sánchez Lafuente, P.J. Vera García, P. Cerezuela Fuentes   +2 more
doaj   +3 more sources

Baseline demographics in patients with locally advanced basal cell carcinoma in Cohort 1.

, 2022
Baseline demographics in patients with locally advanced basal cell carcinoma in Cohort 1.
Simon Yoo (11949194), Aleksandar Sekulic (3192720), Laura Chu (1891477), Edward McKenna (4030052), Yong Mun (9200749), Julie Guillen (11949200), Ragini Kudchadkar (11949197), Gary Rogers (505210), Keith Dawson (11949209), Scott Guenthner (11949203), Mario Lacouture (11949212), Anne Lynn S. Chang (3339900), Bernard Raskin (11949206)   +12 more
core   +1 more source

Baseline disease characteristics in patients with locally advanced basal cell carcinoma in Cohort 1.

, 2022
Baseline disease characteristics in patients with locally advanced basal cell carcinoma in Cohort 1.
Simon Yoo (11949194), Aleksandar Sekulic (3192720), Laura Chu (1891477), Edward McKenna (4030052), Yong Mun (9200749), Julie Guillen (11949200), Ragini Kudchadkar (11949197), Gary Rogers (505210), Keith Dawson (11949209), Scott Guenthner (11949203), Mario Lacouture (11949212), Anne Lynn S. Chang (3339900), Bernard Raskin (11949206)   +12 more
core   +1 more source

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma

Frontiers in Oncology, 2020
Basal cell carcinoma (BCC) accounts for almost 80% of skin cancers, and its healthcare workload burden is substantial within dermatology departments. Although most BCCs are small, well-defined tumors amenable of surgery or conservative procedures, in a ...
Gabriella Brancaccio, Federico Pea, Federico Pea, Elvira Moscarella, Giuseppe Argenziano   +4 more
doaj   +1 more source

Clinical Clearance Following Improvement of Histologic Subtype of Basal Cell Carcinoma with Sonidegib

Acta Dermato-Venereologica, 2022
is missing (Short communication)
Liang Joo Leow, Vicki Howard
doaj   +1 more source

A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck [PDF]

, 2005
Objective: The purpose of this pilot study was to evaluate the feasibility and toxicity of concurrent chemotherapy with vinorelbine and mitomycin C in combination with accelerated radiotherapy (RT) in patients with locally advanced cancer of the head and
Wilkowski, R., Schalhorn, A., Dellian, M., Dühmke, Eckhart, Pachmann, S., Schymura, B.   +5 more
core   +1 more source

Health insurance coverage, history of psychiatric disorders/dementia, and BCC treatment history in patients with locally advanced basal cell carcinoma in Cohort 1.

, 2022
Abbreviations: BCC, basal cell carcinoma; laBCC, locally advanced basal cell carcinoma. aSpecific diagnoses occurring in 2 or more patients are reported.
Simon Yoo (11949194), Aleksandar Sekulic (3192720), Laura Chu (1891477), Edward McKenna (4030052), Yong Mun (9200749), Julie Guillen (11949200), Ragini Kudchadkar (11949197), Gary Rogers (505210), Keith Dawson (11949209), Scott Guenthner (11949203), Mario Lacouture (11949212), Anne Lynn S. Chang (3339900), Bernard Raskin (11949206)   +12 more
core   +1 more source

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma

, 2022
Non-melanoma skin cancers, also known as keratinocyte tumors, have an increasing incidence worldwide, with basal cell carcinoma and squamous cell carcinoma being the most represented ones.
Fabbrocini G., Villani A., Scalvenzi M., Potestio L., Luca Potestio, Gabriella Fabbrocini, Alessia Villani, Massimiliano Scalvenzi   +7 more
core   +1 more source

FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma [PDF]

Clinical Cancer Research, 2017
Abstract On July 24, 2015, the FDA approved sonidegib (ODOMZO; Novartis) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) not amenable to curative surgery or radiotherapy. The approval was based on data from one randomized, double-blind, noncomparative trial of two doses of sonidegib administered to 230 ...
Denise, Casey, Suzanne, Demko, Stacy, Shord, Hong, Zhao, Huanyu, Chen, Kun, He, Alexander, Putman, Whitney, Helms, Patricia, Keegan, Richard, Pazdur   +9 more
openaire   +2 more sources

Anal and rectal locally advanced basal cell carcinoma treated with sonidegib

Dermatologic Therapy, 2021
N ...
Conforti, Claudio, Toffoli, Ludovica, Degrassi, Ferruccio, di Meo, Nicola, Zalaudek, Iris   +4 more
openaire   +3 more sources